Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01161
|
|||||
| Drug Name |
Ajmaline
|
|||||
| Synonyms |
Ajmaline; Cardiorythmine; Ajmalin; Raugalline; Tachmalin; Gilurytmal; (+)-Ajmaline; Aritmina; Rauwolfine; Rhytmaton; Rauwolfin; Merabitol; Takycor; Siddiqui; Rytmalin; Ignazin; Ritmos; 4360-12-7; UNII-1PON08459R; 1PON08459R; Takhmalin; Cartagine; Tajmalin; NSC 15627; Ajmaline [JAN]; Ajmalan-17,21-diol; EINECS 224-439-4; NSC 628054; (17R,21alpha)-Ajmalan-17,21-diol; (17R,21-alpha)-Ajmalan-17,21-diol; AI3-62668; Ajmalan-17,21-diol, (17R,21alpha)-, compound with methanol (1:1); ZINC898188
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Atrial fibrillation [ICD11: BC81.3] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H26N2O2
|
|||||
| Canonical SMILES |
CCC1C2CC3C4C5(CC(C2C5O)N3C1O)C6=CC=CC=C6N4C
|
|||||
| InChI |
InChI=1S/C20H26N2O2/c1-3-10-11-8-14-17-20(12-6-4-5-7-13(12)21(17)2)9-15(16(11)18(20)23)22(14)19(10)24/h4-7,10-11,14-19,23-24H,3,8-9H2,1-2H3/t10-,11-,14-,15-,16-,17-,18+,19+,20+/m0/s1
|
|||||
| InChIKey |
CJDRUOGAGYHKKD-RQBLFBSQSA-N
|
|||||
| CAS Number |
CAS 4360-12-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 326.4 | Topological Polar Surface Area | 46.9 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
1.8
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | The Drugs.com International Drug Name Database: ajmaline | |||||
| 2 | ATP-dependent transport of amphiphilic cations across the hepatocyte canalicular membrane mediated by mdr1 P-glycoprotein. FEBS Lett. 1994 Apr 25;343(2):168-72. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.